# Jiangsu Pudi Biological Technology Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/jiangsu-pudi-biological-technology-co

- Industry: Medical Devices & Equipment
- Headquarters: Taizhou, China
- Latest round: Series A (May 3, 2017)
- Investors on record: 1

## About

Established in 2014 and based in Taizhou, China, Jiangsu Pudi Biological Technology Co., Ltd. operates as a diagnostic reagent developer dedicated to providing in vitro diagnostic reagent, multiple immunodiagnostic reagent and relevant products and testing service. In May 2017, the company closed series A funding from new investor CD Capital. 

The company mainly provides diagnostic reagents. The products cover areas such as autoimmune diseases and tumour marker testing, including liquid phase chip multiplex detection kits for cardiovascular diseases and liquid phase chip multiplex detection kits for hepato-kidney toxicity.

The company generates revenue by providing in vitro diagnostic reagent, multiple immunodiagnostic reagent and relevant products and testing service.

## Funding rounds

- Series A, May 3, 2017 — CD Capital

## Investors

- CD Capital — Series A